Progesterone: Difference between revisions

wikademia>JWSchmidt
News reports
wikademia>JWSchmidt
Brest cancer incidence
Line 11: Line 11:


===Lawsuits===
===Lawsuits===
October 30, 2007. "Wyeth is facing more than 5,000 lawsuits from those who believe they were harmed by the hormone replacement drugs, which have been used by millions of women to control the effects of menopause."<ref>[http://www.reuters.com/article/healthNews/idUSSAT10032420071031 Judge dismisses hormone case against Wyeth], [[w:Reuters|Reuters]], 30 October, 2007.</ref> [[w:Wyeth|Wyeth]] is the manufacturer of [[w:Premarin|Premarin]] and Prepro, a mixture of [[w:Medroxyprogesterone|medroxyprogesterone]] and Premarin. The [[w:Women's Health Initiative|Women's Health Initiative]] estrogen-plus-progestin study reported an increased rate of breast cancer for women using Prempro.<ref>"[http://jama.ama-assn.org/cgi/content/full/288/3/321 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial]" by J. E. Rossouw, G. L. Anderson and R.L. Prentice in ''[w:Journal of the American Medical Association|Journal of the American Medical Association]]'' (2002) Volume 288, pages=321-333.</ref>
October 30, 2007. "Wyeth is facing more than 5,000 lawsuits from those who believe they were harmed by the hormone replacement drugs, which have been used by millions of women to control the effects of menopause."<ref>[http://www.reuters.com/article/healthNews/idUSSAT10032420071031 Judge dismisses hormone case against Wyeth], [[w:Reuters|Reuters]], 30 October, 2007.</ref> [[w:Wyeth|Wyeth]] is the manufacturer of [[w:Premarin|Premarin]] and Prepro, a mixture of [[w:Medroxyprogesterone|medroxyprogesterone]] and Premarin.  
 
The [[w:Women's Health Initiative|Women's Health Initiative]] estrogen-plus-progestin study reported an increased rate of breast cancer for women using Prempro.<ref>"[http://jama.ama-assn.org/cgi/content/full/288/3/321 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial]" by J. E. Rossouw, G. L. Anderson and R.L. Prentice in ''[[w:Journal of the American Medical Association|Journal of the American Medical Association]]'' (2002) Volume 288, pages 321-333.</ref> The [[w:Food and Drug Administration|Food and Drug Administration]] now requires that the Women's Health Initiative results for breast cancer be provided to patients who use Prempro ([http://www.fda.gov/cder/foi/label/2006/020527s037lbl.pdf Label]).
 
===Brest cancer incidence===
December 15, 2006. Following the release of results from the WHI Prempro clinical trial (see above), "Within six months, the drug's sales had fallen by 50 percent." Breast cancer incidence also declined during this time: "The reason, researchers believe, may be that millions of women during that time abandoned hormone treatment for the symptoms of menopause"<ref>[http://www.iht.com/articles/2006/12/15/news/breast.php Breast cancer rates drop 15% from August 2002 to December 2003] by [[w:Gina Kolata|Gina Kolata]] December 15, 2006, in [[w:International Herald Tribune|International Herald Tribune]].</ref>
 
[[w:Epidemiology|Epidemiological]] studies report that since women started to become aware of the risks associated with progestin use, decreases in incidence of breast cancer parallels the decline in progestin use, consistent with the known increased risk of breast cancer among women who use progestins.<ref>"Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin" by G. A. Colditz in ''Breast Cancer Res.'' (2007) Volume 9, page 108.</ref>


==References==
==References==